Journal of Clinical Oncology, Vol 25, No 18 (June 20), 2007: pp. 2586-2593
© 2007 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2006.09.4565
Intratumoral Balance of Regulatory and Cytotoxic T Cells Is Associated With Prognosis of Hepatocellular Carcinoma After Resection
Qiang Gao,
Shuang-Jian Qiu,
Jia Fan,
Jian Zhou,
Xiao-Ying Wang,
Yong-Sheng Xiao,
Yang Xu,
Yi-Wei Li,
Zhao-You Tang
From the Liver Cancer Institute, Zhong Shan Hospital and Shanghai Medical School, Fudan University, Key Laboratory for Carcinogenesis & Cancer Invasion, the Chinese Ministry of Education, Shanghai, People's Republic of China
Address reprint requests to Jia Fan, MD, PhD, Liver Cancer Institute, Fudan University, 136 Yi Xue Yuan Rd, Shanghai 200032, People's Republic of China; e-mail: jiafan99{at}yahoo.com
Purpose To investigate the prognostic value of tumor-infiltrating lymphocytes (TILs), especially regulatory T cells (Tregs), in hepatocellular carcinoma (HCC) patients after resection.
Patients and Methods CD3+, CD4+, CD8+, Foxp3-positive, and granzyme B-positive TILs were assessed by immunohistochemistry in tissue microarrays containing HCC from 302 patients. Prognostic effects of low- or high-density TIL subsets were evaluated by Cox regression and Kaplan-Meier analysis using median values as cutoff.
Results CD3+, CD4+, CD8+ TILs were associated with neither overall survival (OS) nor disease-free survival (DFS). The presence of low intratumoral Tregs in combination with high intratumoral activated CD8+ cytotoxic cells (CTLs), a balance toward CTLs, was an independent prognostic factor for both improved DFS (P = .001) and OS (P < .0001). Five-year OS and DFS rates were only 24.1% and 19.8% for the group with intratumoral high Tregs and low activated CTLs, compared with 64.0% and 59.4% for the group with intratumoral low Tregs and high activated CTLs, respectively. Either intratumoral Tregs alone (P = .001) or intratumoral activated CTLs (P = .001) alone is also an independent predictor for OS. In addition, high Tregs density was associated with both absence of tumor encapsulation (P = .032) and presence of tumor vascular invasion (P = .031).
Conclusion Tregs are associated with HCC invasiveness, and intratumoral balance of regulatory and cytotoxic T cells is a promising independent predictor for recurrence and survival in HCC. A combination of depletion of Tregs and concomitant stimulation of effector T cells may be an effective immunotherapy to reduce recurrence and prolong survival after surgery.
Supported by grants from the National Natural Science Foundation of China (Grant No. 30200268) and the Foundation of China National "211" Project for Higher Education.
Authors disclosures of potential conflicts of interest and author contributions are found at the end of this article.

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Badoual, S. Hans, W. H. Fridman, D. Brasnu, S. Erdman, and E. Tartour
Revisiting the Prognostic Value of Regulatory T Cells in Patients With Cancer
J. Clin. Oncol.,
July 1, 2009;
27(19):
e5 - e6.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Salama, C. Platell, and B. Iacopetta
Reply to C. Badoual et al
J. Clin. Oncol.,
July 1, 2009;
27(19):
e7 - e7.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Andersson, S.-C. Yang, M. Huang, L. Zhu, U. K. Kar, R. K. Batra, D. Elashoff, R. M. Strieter, S. M. Dubinett, and S. Sharma
IL-7 Promotes CXCR3 Ligand-Dependent T Cell Antitumor Reactivity in Lung Cancer
J. Immunol.,
June 1, 2009;
182(11):
6951 - 6958.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-J. Ju, S.-J. Qiu, J. Fan, Y.-S. Xiao, Q. Gao, J. Zhou, Y.-W. Li, and Z.-Y. Tang
Peritumoral Activated Hepatic Stellate Cells Predict Poor Clinical Outcome in Hepatocellular Carcinoma After Curative Resection
Am J Clin Pathol,
April 1, 2009;
131(4):
498 - 510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Gao, X.-Y. Wang, S.-J. Qiu, I. Yamato, M. Sho, Y. Nakajima, J. Zhou, B.-Z. Li, Y.-H. Shi, Y.-S. Xiao, et al.
Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma
Clin. Cancer Res.,
February 1, 2009;
15(3):
971 - 979.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Salama, M. Phillips, F. Grieu, M. Morris, N. Zeps, D. Joseph, C. Platell, and B. Iacopetta
Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer
J. Clin. Oncol.,
January 10, 2009;
27(2):
186 - 192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Abou-Ghazal, D. S. Yang, W. Qiao, C. Reina-Ortiz, J. Wei, L.-Y. Kong, G. N. Fuller, N. Hiraoka, W. Priebe, R. Sawaya, et al.
The Incidence, Correlation with Tumor-Infiltrating Inflammation, and Prognosis of Phosphorylated STAT3 Expression in Human Gliomas
Clin. Cancer Res.,
December 15, 2008;
14(24):
8228 - 8235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-B. Ding, Y.-H. Shi, J. Zhou, S.-J. Qiu, Y. Xu, Z. Dai, G.-M. Shi, X.-Y. Wang, A.-W. Ke, B. Wu, et al.
Association of Autophagy Defect with a Malignant Phenotype and Poor Prognosis of Hepatocellular Carcinoma
Cancer Res.,
November 15, 2008;
68(22):
9167 - 9175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.-H. Yang, J. Fan, Y. Xu, S.-J. Qiu, X.-R. Yang, G.-M. Shi, B. Wu, Z. Dai, Y.-K. Liu, Z.-Y. Tang, et al.
Osteopontin Combined with CD44, a Novel Prognostic Biomarker for Patients with Hepatocellular Carcinoma Undergoing Curative Resection
Oncologist,
November 1, 2008;
13(11):
1155 - 1165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Heimberger, M. Abou-Ghazal, C. Reina-Ortiz, D. S. Yang, W. Sun, W. Qiao, N. Hiraoka, and G. N. Fuller
Incidence and Prognostic Impact of FoxP3+ Regulatory T Cells in Human Gliomas
Clin. Cancer Res.,
August 15, 2008;
14(16):
5166 - 5172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-R. Yang, Y. Xu, G.-M. Shi, J. Fan, J. Zhou, Y. Ji, H.-C. Sun, S.-J. Qiu, B. Yu, Q. Gao, et al.
Cytokeratin 10 and Cytokeratin 19: Predictive Markers for Poor Prognosis in Hepatocellular Carcinoma Patients after Curative Resection
Clin. Cancer Res.,
June 15, 2008;
14(12):
3850 - 3859.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-D. Zhu, J.-B. Zhang, P.-Y. Zhuang, H.-G. Zhu, W. Zhang, Y.-Q. Xiong, W.-Z. Wu, L. Wang, Z.-Y. Tang, and H.-C. Sun
High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular Carcinoma
J. Clin. Oncol.,
June 1, 2008;
26(16):
2707 - 2716.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Fonseca and G. Dranoff
Capitalizing on the Immunogenicity of Dying Tumor Cells
Clin. Cancer Res.,
March 15, 2008;
14(6):
1603 - 1608.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. Schreiber
The Use of FoxP3 as a Biomarker and Prognostic Factor for Malignant Human Tumors
Cancer Epidemiol. Biomarkers Prev.,
October 1, 2007;
16(10):
1931 - 1934.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Yakirevich and M. B. Resnick
Regulatory T Lymphocytes: Pivotal Components of the Host Antitumor Response
J. Clin. Oncol.,
June 20, 2007;
25(18):
2506 - 2508.
[Full Text]
[PDF]
|
 |
|
|